AG
BLU

Artal Group’s BELLUS Health Inc. BLU Stock Holding History

Artal Group’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,700,000
Closed -$30.4M – 153
2022
Q4 		$30.4M Sell
3,700,000
-2,300,000
-38% -$21.4M 1.7% 16
2022
Q3 		$63.4M Sell
6,000,000
-1,000,000
-14% -$10.6M 2.7% 6
2022
Q2 		$64.7M Sell
7,000,000
-1,500,000
-18% -$12.3M 3.45% 8
2022
Q1 		$58.5M Hold
8,500,000
– – 2.45% 11
2021
Q4 		$68.4M Buy
8,500,000
+3,250,000
+62% +$21.6M 1.86% 13
2021
Q3 		$32.2M Buy
5,250,000
+500,000
+11% +$1.9M 0.72% 33
2021
Q2 		$14.8M Hold
4,750,000
– – 0.3% 69
2021
Q1 		$18.2M Hold
4,750,000
– – 0.32% 70
2020
Q4 		$14.5M Buy
4,750,000
+4,275,000
+900% +$11.6M 0.31% 74
2020
Q3 		$1.08M Buy
475,000
+331,237
+230% +$939K 0.03% 129
2020
Q2 		$1.48M Buy
+143,763
New +$1.46M 0.04% 129

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group's BLU Position: Q1 2023 in Review

Artal Group sold out of BELLUS Health Inc. (BLU) in Q1 2023, closing a stake of 3,700,000 shares — an estimated $30.4M sold.

Artal Group first reported a position in BLU in Q2 2020 and held it in 11 quarters. The position peaked at $68.4M in Q4 2021. 106 funds tracked by Wall St. Rank hold BLU as of Q1 2023.

  • Artal Group reported no remaining BELLUS Health Inc. position as of Q1 2023 after selling out during the quarter.
  • Artal Group sold 3,700,000 BELLUS Health Inc. shares in Q1 2023, an estimated $30.4M.
  • Artal Group first reported a position in BELLUS Health Inc. in Q2 2020 and held it in 11 quarters.
  • Artal Group's BELLUS Health Inc. position peaked at $68.4M in Q4 2021.
  • 106 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2023.

Based on Artal Group's 13F filing for Q1 2023, filed 12 May 2023.